[1] Nobile CJ, Johnson AD. Candida albicans biofilms and human disease[J]. Annu Rev Microbiol, 2015, 69:71-92.
[2] Teymuri M, Mamishi S, Pourakbari B, et al. Investigation of ERG11 gene expression among fluconazole-resistant Candida albicans:first report from an Iranian referral paediatric hospital[J]. Br J Biomed Sci, 2015, 72(1):28-31.
[3] Schubert S, Barker KS, Znaidi S, et al. Regulation of efflux pump expression and drug resistance by the transcription[J]. Antimicrob Agents Chemother, 2011, 55(5):2212-2223.
[4] Morio F, Pagniez F, Lacroix C, et al. Amino acid substitutions in the Candida albicans sterol Delta5,6-desaturase[J]. J. Antimicrob. Chemother, 2012, 67(9):2131-2138.
[5] Liu JY, Shi C, Wang Y, et al. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China[J]. Res Microbiol, 2015, 166(3):153-161.
[6] Xie JL, Qin L, Miao Z, et al.The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation[J]. Nat Commun, 2017, 8(1):499.
[7] Liu Z, Myers LC. Mediator tail module is required for Tac1-activated CDR1 expression and azole[J]. Antimicrob Agents Chemother, 2017, 61(11):e01342-17.
[8] Jensen RH, Astvad KM, Silva LV, et al. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance[J]. J Antimicrob Chemother, 2015, 70(9):2551-2555.
[9] Wang Y, Liu J, Shi C, et al. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans[J]. Int J Antimicrob Agents, 2015, 46(5):552-559.
[10] Lo HJ, Tseng KY, Kao YY, et al. Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans[J].Int J Antimicrob Agents, 2015, 45(6):617-621.
[11] 李翠, 吴永琴, 陈艺升,等. 白念珠菌临床分离株吡咯类耐药机制研究[J]. 中国感染与化疗杂志, 2017, 17(4):397-403.
[12] Sanglard D, Ischer F, Marchetti O, et al. Calcineurin A of Candida albicans:involvement in antifungal tolerance, cell morphogenesis and virulence[J]. Mol Microbiol, 2003, 48(4):959-976.
[13] Li L, An M, Shen H, et al. The non-Geldanamycin Hsp90 inhibitors enhanced the antifungal activity of fluconazole[J]. Am J Transl Res, 2015, 7(12):2589-2602.
[14] Nobile CJ, Nett JE, Andes DR, et al. Function of Candida albicans adhesin Hwp1 in biofilm formation[J]. Eukaryot Cell, 2006, 5(10):1604-1610.
[15] Johnson CJ, Id-Orcid, Cabezas-Olcoz J, et al. The extracellular matrix of Candida albicans biofilms impairs formation of neutrophil extracellular traps[J]. PLoS Pathog, 2016, 12(9):e1005884.
[16] Roudbarmohammadi S, Roudbary M, Bakhshi B, et al. ALS1 and ALS3 gene expression and biofilm formation in Candida albicans isolated from vulvovaginal candidiasis[J]. Adv Biomed Res, 2016,5:105.
[17] Yan L, Zhang J, Li M, et al. DNA microarray analysis of fluconazole resistance in a laboratory Candida albicans strain[J]. Acta Biochim Biophys Sin (Shanghai), 2008, 40(12):1048-1060.
[18] Yan L, Zhang JD, Cao YB, et al. Proteomic analysis reveals a metabolism shift in a laboratory fluconazole-resistant Candida albicans strain[J]. J Proteome Res, 2007, 6(6):2248-2256.
[19] Yan L, Li M, Cao Y, et al. The alternative oxidase of Candida albicans causes reduced fluconazole susceptibility[J]. J Antimicrob Chemother, 2009, 64(4):764-773.
[20] 闻轶旸, 黄欣, 沈帅帅,等. 基于Hog-MAPK信号通路探讨白念珠菌氟康唑耐药机制的实验研究[J]. 中国真菌学杂志, 2015,10(6):345-351.
[21] Li X, Yang F, Li D, et al. Trisomy of chromosome R confers resistance to triazoles in Candida albicans[J]. Med Mycol, 2015, 53(3):302-309.
[22] Zhu CX, Yan L. Transposition of the Zorro2 retrotransposon is activated by miconazole in Candida albicans[J]. Biol Pharm Bull, 2014, 37(1):37-43.